These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2046273

  • 21. [Clinical study of lipid metabolism disorders (discussion)].
    Nihon Naika Gakkai Zasshi; 1992 Nov 10; 81(11):1836-51. PubMed ID: 1479227
    [No Abstract] [Full Text] [Related]

  • 22. Current and new therapy for hypercholesterolemia.
    Hunninghake DB.
    J Am Osteopath Assoc; 1988 Jul 10; 88(7):865-9. PubMed ID: 3215796
    [No Abstract] [Full Text] [Related]

  • 23. [Treatment of hyperlipidemia].
    Itakura H.
    Nihon Naika Gakkai Zasshi; 1992 Nov 10; 81(11):1750-5. PubMed ID: 1336024
    [No Abstract] [Full Text] [Related]

  • 24. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW, Huff M, Oskalns R, Rudas L, Kostuk WJ.
    J Heart Lung Transplant; 1995 Nov 10; 14(4):613-22. PubMed ID: 7578166
    [Abstract] [Full Text] [Related]

  • 25. [Pharmacological treatment of hyperlipoproteinemias--theory and practice].
    Frisk-Holmberg M.
    Lakartidningen; 1974 Aug 21; 71(34):3083-6. PubMed ID: 4410383
    [No Abstract] [Full Text] [Related]

  • 26. Rational drug therapy of the hyperlipoproteinemias, Part II.
    Blum CB, Levy RI.
    Ration Drug Ther; 1986 Oct 21; 20(10):1-4. PubMed ID: 3472266
    [No Abstract] [Full Text] [Related]

  • 27. Treatment of nephrotic hyperlipidemia with lovastatin.
    Elisaf M, Dardamanis M, Pappas M, Sferopoulos G, Siamopoulos KC.
    Clin Nephrol; 1991 Jul 21; 36(1):50-2. PubMed ID: 1889153
    [No Abstract] [Full Text] [Related]

  • 28. Lack of left ventricular dysfunction associated with sustained exposure to hyperlipidemia following lung transplantation.
    Kesten S, Mayne L, Scavuzzo M, Maurer J.
    Chest; 1997 Oct 21; 112(4):931-6. PubMed ID: 9377955
    [Abstract] [Full Text] [Related]

  • 29. Pathogenesis of lipid abnormalities in patients with nephrotic syndrome/proteinuria: clinical implications.
    Warwick GL, Packard CJ.
    Miner Electrolyte Metab; 1993 Oct 21; 19(3):115-26. PubMed ID: 8232098
    [Abstract] [Full Text] [Related]

  • 30. Efficacy, tolerance, and safety of colestipol HCL as a hypocholesterolemic agent in hyperlipidemic patients with studies of its effect on gastrointestinal absorption.
    Faruqui AM, Thurmond MS, Wenger J, Wenger NK.
    J Pak Med Assoc; 1981 Nov 21; 31(11):241-5. PubMed ID: 6802993
    [No Abstract] [Full Text] [Related]

  • 31. Hypertriglyceridemia: a relative contraindication to the use of bile acid-binding resins?
    Denke MA, Grundy SM.
    Hepatology; 1988 Nov 21; 8(4):974-5. PubMed ID: 3391527
    [No Abstract] [Full Text] [Related]

  • 32. Lipid-lowering drugs.
    Med Lett Drugs Ther; 1980 Aug 08; 22(16):65-6. PubMed ID: 7402175
    [No Abstract] [Full Text] [Related]

  • 33. Bile acid sequestrants and hyperlipidaemia.
    Lancet; 1988 Jan 30; 1(8579):220-1. PubMed ID: 2893044
    [No Abstract] [Full Text] [Related]

  • 34. Hyperlipidemia and hypertension: impact of steroid withdrawal.
    Van Buren CT.
    Transplant Proc; 1993 Aug 30; 25(4 Suppl 3):30-2. PubMed ID: 8351711
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.